• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Vitrolife

95.75 SEK

-0.47 %

Less than 1K followers

VITR

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-0.47 %
-11.75 %
+1.86 %
-30.11 %
-30.92 %
-35.65 %
-55.34 %
-72.66 %
+1,460.21 %

Vitrolife is an international group that provides medical devices and genetic services. The company develops and manufactures services and products for personalized genetic information as well as medical devices in the field of fertility. Vitrolife supports customers in their operations to improve patient outcomes from fertility treatments. Vitrolife's products and services are available globally. The company is headquartered in Gothenburg, Sweden.

Read more
Market cap
12.97B SEK
Turnover
71.5M SEK
Revenue
3.44B
EBIT %
-140.55 %
P/E
-
Dividend yield-%
1.15 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
16/7
2026

Interim report Q2'26

22/10
2026

Interim report Q3'26

28/1
2027

Annual report '26

Regulatory press releaseyesterday

Finansinspektionen: Flaggningsmeddelande i Vitrolife AB

Vitrolife
Press release6/1/2026, 10:00 AM

Vitrolife AB (publ): Vitrolife Group appoints Olivier Desmarets as Chief Operations Officer following Ermanno Sironi's retirement

Vitrolife
Press release6/1/2026, 10:00 AM

Vitrolife AB (publ): Vitrolife Group utser Olivier Desmarets till Chief Operations Officer i samband med Ermanno Sironis pensionering

Vitrolife

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/22/2026, 10:00 AM

Vitrolife AB (publ): VD Bronwyn Brophy O'Connor har beslutat sig för att lämna Vitrolife Group

Vitrolife
Regulatory press release5/22/2026, 10:00 AM

Vitrolife AB (publ): CEO Bronwyn Brophy O'Connor has decided to leave Vitrolife Group

Vitrolife
Regulatory press release5/5/2026, 4:30 PM

Kommuniké från årsstämma i Vitrolife AB (publ)

Vitrolife
Regulatory press release5/5/2026, 4:30 PM

Report from the Annual General Meeting of Vitrolife AB (publ)

Vitrolife
Press release4/24/2026, 7:41 AM

Redeye: Vitrolife (Q1 review): Fx-headwind but solid profitability

Vitrolife
Vitrolife, Audiocast, Q1'26
Webcast4/23/2026, 8:00 AM

Vitrolife, Audiocast, Q1'26

Vitrolife
Regulatory press release4/23/2026, 6:00 AM

Vitrolife AB (publ): Delårsrapport Q1, 2026: Stark tillväxt inom Consumables och Tehnologies

Vitrolife
Regulatory press release4/23/2026, 6:00 AM

Vitrolife AB (publ): Interim report Q1, 2026: Strong growth in Consumables and Technologies

Vitrolife
Press release4/9/2026, 7:00 AM

Vitrolife AB (publ): Invitation to Vitrolife Group's presentation of the Q1 2026 interim report

Vitrolife
Press release4/9/2026, 7:00 AM

Vitrolife AB (publ): Inbjudan till Vitrolife Groups presentation av delårsrapporten för Q1 2026

Vitrolife
Regulatory press release4/1/2026, 4:00 PM

Kallelse till årsstämman i Vitrolife AB (publ)

Vitrolife
Regulatory press release4/1/2026, 4:00 PM

Notice of the Annual General Meeting of Vitrolife AB (publ)

Vitrolife
Regulatory press release4/1/2026, 3:50 PM

Vitrolife AB (publ): The Nomination Committee proposes two new Board members

Vitrolife
Regulatory press release4/1/2026, 3:50 PM

Vitrolife AB (publ): Valberedningen föreslår två nya styrelseledamöter

Vitrolife
Regulatory press release3/26/2026, 8:00 AM

Vitrolife AB (publ): Vitrolife Group har idag publicerat sin års- och hållbarhetsredovisning för 2025

Vitrolife
Regulatory press release3/26/2026, 8:00 AM

Vitrolife AB (publ): Vitrolife Group has today published its Annual and Sustainability Report for 2025

Vitrolife
Regulatory press release2/4/2026, 1:38 PM

Finansinspektionen: Flaggningsmeddelande i Vitrolife AB

Vitrolife